OncoImmunology Publication Validates Need to Determine Specific Subset of Mutations that Elicit Cancer Therapy Response SAN DIEGO, CA – February 7, 2017 – CureMatch, the developer of a Decision Support System for combination therapy in cancer, today revealed in the peer-reviewed journal OncoImmunology the description of a specific mechanism that can potentially be used for selecting […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.